NORTHERN TRUST CORP - AMPIO PHARMACEUTICALS INC ownership

AMPIO PHARMACEUTICALS INC's ticker is AMPE and the CUSIP is 03209T109. A total of 98 filers reported holding AMPIO PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of AMPIO PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$20,000
-64.9%
336,9090.0%0.00%
Q2 2022$57,000
-93.0%
336,909
-80.5%
0.00%
Q1 2022$811,000
-21.2%
1,725,267
-4.4%
0.00%
Q4 2021$1,029,000
-65.4%
1,804,450
+0.6%
0.00%
-100.0%
Q3 2021$2,978,000
-3.6%
1,794,161
-3.0%
0.00%0.0%
Q2 2021$3,090,000
+425.5%
1,850,262
+431.6%
0.00%
Q1 2021$588,000
+20.2%
348,046
+13.2%
0.00%
Q4 2020$489,000
+81.1%
307,584
+8.9%
0.00%
Q3 2020$270,000
+67.7%
282,352
+11.8%
0.00%
Q2 2020$161,000
+94.0%
252,635
+26.7%
0.00%
Q1 2020$83,000
-11.7%
199,368
+23.0%
0.00%
Q4 2019$94,000
+16.0%
162,0410.0%0.00%
Q3 2019$81,000
-80.0%
162,041
-84.5%
0.00%
Q2 2019$405,000
-34.7%
1,044,724
-5.2%
0.00%
Q1 2019$620,000
+62.3%
1,101,846
+13.8%
0.00%
Q4 2018$382,000
-27.7%
967,914
-6.8%
0.00%
Q3 2018$528,000
-71.8%
1,038,953
+22.1%
0.00%
Q2 2018$1,872,000
+293.3%
850,903
+507.8%
0.00%
Q1 2018$476,000
-16.5%
139,992
-0.1%
0.00%
Q4 2017$570,000
+975.5%
140,156
+60.6%
0.00%
Q3 2017$53,000
+17.8%
87,2890.0%0.00%
Q2 2017$45,000
-88.5%
87,289
-82.1%
0.00%
Q1 2017$390,000
-9.1%
488,476
+2.4%
0.00%
Q4 2016$429,000
+21.2%
477,210
-0.2%
0.00%
Q3 2016$354,000
-43.0%
477,950
-0.8%
0.00%
Q2 2016$621,000
+281.0%
481,779
+566.3%
0.00%
Q1 2016$163,000
-35.6%
72,3100.0%0.00%
Q4 2015$253,000
+21.6%
72,310
+0.1%
0.00%
Q3 2015$208,000
-77.1%
72,255
-81.2%
0.00%
Q2 2015$909,000
-71.9%
383,367
-10.6%
0.00%
-100.0%
Q1 2015$3,230,000
+121.2%
429,047
+0.8%
0.00%
Q4 2014$1,460,000
-5.1%
425,557
-2.3%
0.00%
Q3 2014$1,538,000
-57.7%
435,674
+0.0%
0.00%
-100.0%
Q2 2014$3,637,000
+34.7%
435,559
+2.4%
0.00%0.0%
Q1 2014$2,700,000
-11.9%
425,166
-1.1%
0.00%0.0%
Q4 2013$3,063,000
+6.2%
429,771
+11.7%
0.00%0.0%
Q3 2013$2,884,000
+52.0%
384,647
+17.0%
0.00%0.0%
Q2 2013$1,897,000328,7570.00%
Other shareholders
AMPIO PHARMACEUTICALS INC shareholders Q3 2022
NameSharesValueWeighting ↓
CVA Family Office, LLC 1,173,200$1,865,0001.14%
PRIVATE CAPITAL MANAGEMENT LLC 937,237$1,387,0000.82%
Cypress Capital Management LLC (WY) 214,575$341,0000.30%
Western Wealth Management, LLC 982,350$1,562,0000.23%
SRS Capital Advisors, Inc. 615,659$979,0000.14%
Willis Investment Counsel 1,213,053$1,929,0000.13%
Harvest Investment Services, LLC 124,423$197,0000.10%
Transform Wealth, LLC 205,481$327,0000.07%
COURIER CAPITAL LLC 379,973$604,0000.07%
BRIGHTON JONES LLC 398,912$634,0000.04%
View complete list of AMPIO PHARMACEUTICALS INC shareholders